/Investor DB

Andera Partners — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Cyllene Therapeuticscyllene-tx.comSeries B · Jul 2026 · $28M

Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders.

BiotechDeep TechDigital HealthParis, FR

Philippe Chambon MD, PhD(Founder)inPhilippe Chambon(Founder, Chairman & CEO)Alberto Epstein(Founder & CSO)Cornelia Haag-Molkenteller(CMO)Samuel Salot(COO)Marc Grasso(CFO)

Co-investorsBpifranceM VenturesSCI Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.